FDA vs COFEPRIS: What Stem Cell Patients Need to Know (2026)
Medical Tourism in Mexico
FDA vs COFEPRIS: What Stem Cell Patients Need to Know (2026)
A factual comparison of the FDA and COFEPRIS frameworks for stem cell therapy: what is approved in the US versus Mexico, the HCT/P 361 vs 351 distinction, and how patients can verify legitimacy in either country.
May 27, 2026·11 min read·By Misael González
Read full article: FDA vs COFEPRIS: What Stem Cell Patients Need to Know (2026) →